Duncker Streett & Co’s GeoVax Labs GOVX Stock Holding History

Duncker Streett & Co’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$58	–	540
2024 Q3	$58	Buy	+1	New	+$84	﹤0.01%	485

Other funds holding GOVX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SSG

Summit Securities Group New York $1.05B AUM 36.17% 1-Year Est. Return

Duncker Streett & Co's GOVX Position: Q4 2024 in Review

Duncker Streett & Co sold out of GeoVax Labs (GOVX) in Q4 2024, closing a stake of 1 share — an estimated $58 sold.

Duncker Streett & Co first reported a position in GOVX in Q3 2024 and held it in 1 quarter. The position peaked at $58 in Q3 2024. 16 funds tracked by Wall St. Rank hold GOVX as of Q4 2024.

Duncker Streett & Co reported no remaining GeoVax Labs position as of Q4 2024 after selling out during the quarter.
Duncker Streett & Co sold 1 GeoVax Labs share in Q4 2024, an estimated $58.
Duncker Streett & Co first reported a position in GeoVax Labs in Q3 2024 and held it in 1 quarter.
Duncker Streett & Co's GeoVax Labs position peaked at $58 in Q3 2024.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q4 2024.

Based on Duncker Streett & Co's 13F filing for Q4 2024, filed 5 Feb 2025.